Literature DB >> 16682474

Peripheral blood mononuclear cells from individuals infected with human T-cell lymphotropic virus type 1 have a reduced capacity to respond to recall antigens.

Rita Elizabeth Mascarenhas1, Cláudia Brodskyn, Geisa Barbosa, Jorge Clarêncio, Antônio Souza Andrade-Filho, Frederico Figueiroa, Bernardo Galvão-Castro, Fernanda Grassi.   

Abstract

Evidence indicates that human T-cell lymphotropic virus type 1 (HTLV-1) infection leads to chronic immunosuppression and a greater susceptibility to infectious diseases. Spontaneous in vitro proliferation of peripheral blood mononuclear cells (PBMC) is an important immunological feature of HTLV-1-infected individuals. However, the association between spontaneous proliferation and immunosuppression is not clear. In this study, we evaluated the cellular immune responses of PBMC from 58 asymptomatic HTLV-1-infected individuals with PBMC showing or not showing spontaneous proliferation. Individuals with PBMC that spontaneously proliferated had increased proportions of CD4 T cells expressing CD45RO and dramatically reduced responses to recall antigens. In addition, frequencies of positive responses to recall antigens were also decreased in HTLV-infected individuals without spontaneous proliferation of PBMC. There was a polyclonal expansion of multiple T-cell receptor Vbeta families of CD4+ T lymphocytes in patients with spontaneous proliferation. We observed that HTLV-1 induced an immunosuppression characterized by a decrease in the stimulation index to a recall antigen, even in individuals who did not present spontaneous proliferation. On the other hand, only patients with PBMC presenting spontaneous proliferation showed polyclonal activation and increased proportion of CD4 T cells expressing CD45RO.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16682474      PMCID: PMC1459653          DOI: 10.1128/CVI.13.5.547-552.2006

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  36 in total

1.  Distribution of human T-lymphotropic virus type I among blood donors: a nationwide Brazilian study.

Authors:  B Galvão-Castro; L Loures; L G Rodriques; A Sereno; O C Ferreira Júnior; L G Franco; M Muller; D A Sampaio; A Santana; L M Passos; F Proietti
Journal:  Transfusion       Date:  1997-02       Impact factor: 3.157

2.  Spontaneous lymphocyte proliferation in symptom-free HTLV-I positive Jamaicans.

Authors:  A Krämer; S Jacobson; J F Reuben; E L Murphy; S Z Wiktor; B Cranston; J P Figueroa; B Hanchard; D McFarlin; W A Blattner
Journal:  Lancet       Date:  1989-10-14       Impact factor: 79.321

3.  HTLV-1 and polymyositis in Jamaica.

Authors:  O S Morgan; P Rodgers-Johnson; C Mora; G Char
Journal:  Lancet       Date:  1989-11-18       Impact factor: 79.321

4.  Decreased reactivity to PPD among HTLV-I carriers in relation to virus and hematologic status.

Authors:  S L Welles; N Tachibana; A Okayama; S Shioiri; S Ishihara; K Murai; N E Mueller
Journal:  Int J Cancer       Date:  1994-02-01       Impact factor: 7.396

5.  Arthritis in a human T lymphotropic virus type I (HTLV-I) carrier.

Authors:  S Ijichi; T Matsuda; I Maruyama; T Izumihara; K Kojima; T Niimura; Y Maruyama; S Sonoda; A Yoshida; M Osame
Journal:  Ann Rheum Dis       Date:  1990-09       Impact factor: 19.103

6.  HTLV-I/II prevalence in different geographic locations.

Authors:  Hans Vrielink; Henk W Reesink
Journal:  Transfus Med Rev       Date:  2004-01

7.  Immunoepidemiologic studies of Strongyloides stercoralis and human T lymphotropic virus type I infections in Jamaica.

Authors:  R D Robinson; J F Lindo; F A Neva; A A Gam; P Vogel; S I Terry; E S Cooper
Journal:  J Infect Dis       Date:  1994-03       Impact factor: 5.226

8.  Seroepidemiology of human T-cell lymphotropic virus type I/II in northeastern Brazil.

Authors:  E D Moreira; T T Ribeiro; P Swanson; C Sampaio Filho; A Melo; C Brites; R Badaró; G Toedter; H Lee; W Harrington
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1993-08

9.  Impairment of cell-mediated immune responses in HTLV-I-associated myelopathy.

Authors:  Y Kuroda; H Takashima
Journal:  J Neurol Sci       Date:  1990-12       Impact factor: 3.181

10.  Infection with human immunodeficiency virus type 1 (HIV-1) and human T cell lymphotropic viruses among leprosy patients and contacts: correlation between HIV-1 cross-reactivity and antibodies to lipoarabinomannan.

Authors:  O Kashala; R Marlink; M Ilunga; M Diese; B Gormus; K Xu; P Mukeba; K Kasongo; M Essex
Journal:  J Infect Dis       Date:  1994-02       Impact factor: 5.226

View more
  14 in total

1.  Increased all-cause and cancer mortality in HTLV-II infection.

Authors:  Hope H Biswas; Zhanna Kaidarova; George Garratty; Joan W Gibble; Bruce H Newman; James W Smith; Alyssa Ziman; Joy L Fridey; Ronald A Sacher; Edward L Murphy
Journal:  J Acquir Immune Defic Syndr       Date:  2010-07       Impact factor: 3.731

Review 2.  Viral modulation of T-cell receptor signaling.

Authors:  Keith R Jerome
Journal:  J Virol       Date:  2008-02-20       Impact factor: 5.103

3.  Association of Tuberculosis Status with Neurologic Disease and Immune Response in HTLV-1 Infection.

Authors:  Anselmo Souza; Natália Carvalho; Yuri Neves; Silvane Braga Santos; Maria de Lourdes Bastos; Sérgio Arruda; Eduardo Martins Netto; Marshall J Glesby; Edgar Carvalho
Journal:  AIDS Res Hum Retroviruses       Date:  2017-06-26       Impact factor: 2.205

4.  Evaluation of the microbicidal activity and cytokines/chemokines profile released by neutrophils from HTLV-1-infected individuals.

Authors:  Caroline A Bezerra; Thiago M Cardoso; Angela Giudice; Aurélia F Porto; Silvane B Santos; Edgar M Carvalho; Olívia Bacellar
Journal:  Scand J Immunol       Date:  2011-09       Impact factor: 3.487

5.  Co-infection by human immunodeficiency virus type 1 (HIV-1) and human T cell leukemia virus type 1 (HTLV-1): does immune activation lead to a faster progression to AIDS?

Authors:  Eduardo Samo Gudo; Nilesh B Bhatt; Dulce Ramalho Bila; Celina Monteiro Abreu; Amílcar Tanuri; Wilson Savino; Suse Dayse Silva-Barbosa; Ilesh V Jani
Journal:  BMC Infect Dis       Date:  2009-12-22       Impact factor: 3.090

6.  Impairment of the humoral and CD4(+) T cell responses in HTLV-1-infected individuals immunized with tetanus toxoid.

Authors:  Anselmo Souza; Silvane Santos; Lucas P Carvalho; Maria Fernanda R Grassi; Edgar M Carvalho
Journal:  Hum Immunol       Date:  2016-06-06       Impact factor: 2.850

7.  Prevalence of human T-cell lymphotropic virus type 1 infection in hospitalized patients with tuberculosis.

Authors:  M de Lourdes Bastos; B Osterbauer; D L Mesquita; C A Carrera; M J Albuquerque; L Silva; D N Pereira; L Riley; E M Carvalho
Journal:  Int J Tuberc Lung Dis       Date:  2009-12       Impact factor: 2.373

Review 8.  HTLV-1 and innate immunity.

Authors:  Chloé Journo; Renaud Mahieux
Journal:  Viruses       Date:  2011-08-08       Impact factor: 5.048

9.  Influence of HTLV-1 on the clinical, microbiologic and immunologic presentation of tuberculosis.

Authors:  Maria de Lourdes Bastos; Silvane B Santos; Anselmo Souza; Brooke Finkmoore; Ohana Bispo; Tasso Barreto; Ingrid Cardoso; Iana Bispo; Flávia Bastos; Daniele Pereira; Lee Riley; Edgar M Carvalho
Journal:  BMC Infect Dis       Date:  2012-08-28       Impact factor: 3.090

10.  IFN-γ production to leishmania antigen supplements the leishmania skin test in identifying exposure to L. braziliensis infection.

Authors:  Daniel Schnorr; Aline C Muniz; Sara Passos; Luiz H Guimaraes; Ednaldo L Lago; Olívia Bacellar; Marshall J Glesby; Edgar M Carvalho
Journal:  PLoS Negl Trop Dis       Date:  2012-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.